Product image of Iomeron (Iomeprol) supplied by GNH India

Iomeron

Active Ingredient:
Iomeprol
Origin:
EU

Iomeron (Iomeprol)

Iomeprol, the active ingredient in Iomeron, is an iodinated contrast media presented as an injectable solution for intraarterial, intraarticular, and intrathecal use. It enhances radiographic visualization of vascular and body cavity structures during imaging procedures.

GNH India supplies Iomeron as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, imaging centres and clinics worldwide, with full regulatory compliance and quality assurance. The company adheres to EU GMP standards and provides batch‑specific certificates of analysis, and supports timely delivery to meet clinical schedules.

Manufacturer / TM Owner

Bracco Imaging Deutschland Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Iomeron, an iodinated contrast agent, is used in radiographic procedures that require enhanced visualization of vascular and body cavity structures.

  • Angiography: Improves delineation of blood vessels during X‑ray angiographic studies.
  • Arthrography: Enhances joint space imaging for better assessment of cartilage and soft tissues.
  • Myelography: Provides clear contrast of the spinal canal and nerve roots in intrathecal examinations.
  • CT imaging: Increases radiodensity to produce high‑resolution computed tomography images of organs and vessels.

How It Works

  • Iomeprol contains a high density of iodine atoms that strongly absorb X‑ray photons. After intravenous or targeted injection, the iodine distributes within the vascular and extracellular compartments, creating localized radiodensity that highlights anatomical structures on X‑ray, fluoroscopy, or CT scans, thereby improving diagnostic image quality.

Side Effects

Iomeron may cause a range of adverse reactions following administration.

Common Side Effects

  • Warm sensation or flushing at the injection site.
  • Nausea or mild vomiting.
  • Metallic taste in the mouth.
  • Headache or mild dizziness.
  • Transient urticaria or mild skin rash.
  • Temporary mild hypotension.

Serious or Rare Side Effects

  • Severe allergic reaction or anaphylaxis.
  • Acute renal impairment, especially in patients with pre‑existing kidney disease.
  • Persistent hypotension requiring medical intervention.
  • Cardiac arrhythmias.
  • Seizures or neurologic disturbances.
  • Pulmonary edema or respiratory distress.

Precautions & Warnings

When using Iomeron, clinicians should observe specific safety measures.

  • Assess renal function: evaluate serum creatinine and eGFR before administration.
  • Screen for iodine or contrast media allergy: obtain detailed allergy history.
  • Use the lowest effective dose: tailor volume to the specific imaging study.
  • Monitor vital signs: observe blood pressure and heart rate during and after injection.
  • Avoid use in pregnancy unless essential: consider risk‑benefit ratio.
  • Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Avoid Interactions

Iomeron can interact with other agents that affect renal function or hemodynamics.

Major Interactions (Avoid)

  • Concurrent administration of other iodinated contrast agents.
  • High‑dose nephrotoxic drugs such as aminoglycosides or amphotericin B.
  • Recent exposure to radiographic contrast within 48 hours.

Moderate Interactions (Monitor Closely)

  • Beta‑blockers may blunt compensatory tachycardia during hypotensive episodes.
  • Loop diuretics can increase risk of contrast‑induced nephropathy.
  • ACE inhibitors or ARBs may potentiate renal effects; monitor kidney function.
  • Antihistamines may mask early allergic signs; observe patient closely.

Frequently Asked Questions

Iomeron is an iodinated contrast medium used to enhance the visibility of blood vessels, joints, the spinal canal, and internal organs during imaging procedures such as angiography, arthrography, myelography, and computed tomography (CT) scans.

Iomeprol contains iodine atoms that absorb X‑ray photons. When injected, it increases the radiodensity of the targeted area, creating a clear contrast between structures on X‑ray, fluoroscopy, or CT images, which helps clinicians identify anatomical details more accurately.

The dose of Iomeron is determined by the prescribing physician based on the specific imaging study, patient weight, renal function, and the required level of contrast. Only a qualified healthcare professional should set the appropriate dosage.

Safety data for Iomeron in pregnancy and lactation are limited. It should be used only if the diagnostic benefit outweighs potential risks, and the decision must be made by the treating physician in consultation with the patient.

To order Iomeron, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Iomeron (Iomeprol) is a low‑osmolality, non‑ionic iodinated contrast medium, offering a favorable safety profile compared with high‑osmolality agents. It provides comparable image quality while reducing the incidence of discomfort and adverse reactions, making it a preferred choice for many radiology departments.

Iomeron should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the solution from moisture, direct sunlight, and extreme temperature fluctuations. Do not freeze or shake the vial before use.

Iomeron is administered by a qualified healthcare professional via intra‑arterial, intra‑articular, or intrathecal injection, depending on the imaging procedure. The injection is performed under aseptic conditions, and the patient is monitored for any immediate reactions.

The most serious risks include severe allergic reactions (anaphylaxis), acute kidney injury, persistent hypotension, cardiac arrhythmias, and rare neurologic events such as seizures. Prompt recognition and management of these reactions are essential.

Iomeron should be avoided in patients with a known allergy to iodinated contrast media, severe renal impairment, uncontrolled hyperthyroidism, or in pregnant women when the diagnostic benefit does not outweigh potential risks. The prescribing clinician must evaluate each case individually.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.